Cargando…

Correction to: Treating primary immunodeficiencies with defects in NK cells: from stem cell therapy to gene editing

Detalles Bibliográficos
Autores principales:	Eguizabal, C., Herrera, L., Inglés-Ferrándiz, M., Belmonte, J. C. Izpisua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080394/ https://www.ncbi.nlm.nih.gov/pubmed/33906672 http://dx.doi.org/10.1186/s13287-021-02281-1

Ejemplares similares

Treating primary immunodeficiencies with defects in NK cells: from stem cell therapy to gene editing
por: Eguizabal, C., et al.
Publicado: (2020)

A Comparative Study of Cell Culture Conditions during Conversion from Primed to Naive Human Pluripotent Stem Cells
por: Romayor, Irene, et al.
Publicado: (2022)

Adenine base editing to mimic or correct disease mutations in rodents
por: Ren, Ruotong, et al.
Publicado: (2018)

Identifying SARS‐CoV‐2 ‘memory’ NK cells from COVID‐19 convalescent donors for adoptive cell therapy
por: Herrera, Lara, et al.
Publicado: (2021)

Correction: PDGFB-expressing mesenchymal stem cells improve human hematopoietic stem cell engraftment in immunodeficient mice
por: Yin, Xiuxiu, et al.
Publicado: (2020)

Correction: Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cells
Publicado: (2022)

Correction: A Src-Tks5 Pathway Is Required for Neural Crest Cell Migration during Embryonic Development
por: Murphy, Danielle A., et al.
Publicado: (2012)

Correction: Correction: Correction: Influenza Virus Targets Class I MHC-Educated NK Cells for Immunoevasion
Publicado: (2017)

Age-related cardiopathies gene editing
por: Song, Moshi, et al.
Publicado: (2019)

Correction: In vitro expansion impaired the stemness of early passage mesenchymal stem cells for treatment of cartilage defects
por: Jiang, Tongmeng, et al.
Publicado: (2019)

Correction: Astrovirus Infection in Hospitalized Infants with Severe Combined Immunodeficiency after Allogeneic Hematopoietic Stem Cell Transplantation
por: Wunderli, Werner, et al.
Publicado: (2012)

Correction: Correction: Influenza Virus Targets Class I MHC-Educated NK Cells for Immunoevasion
Publicado: (2016)

Correction: The enhanced expression of the matrix metalloproteinase 9 in nasal NK/T-cell lymphoma
por: Sakata, Koh-ichi, et al.
Publicado: (2008)

Analysis of the impact of handling and culture on the expansion and functionality of NK cells
por: Martin-Iglesias, Sara, et al.
Publicado: (2023)

Author Correction: Lateral plate mesoderm cell-based organoid system for NK cell regeneration from human pluripotent stem cells
por: Huang, Dehao, et al.
Publicado: (2023)

Publisher Correction: NK cells in COVID-19: protectors or opponents?
por: Alrubayyi, Aljawharah
Publicado: (2020)

Correction: Influenza Virus Targets Class I MHC-Educated NK Cells for Immunoevasion
por: Mahmoud, Ahmad Bakur, et al.
Publicado: (2016)

Correction to: Rescue of premature aging defects in Cockayne syndrome stem cells by CRISPR/Cas9-mediated gene correction
por: Wang, Si, et al.
Publicado: (2022)

Protocol for the generation of blastocyst-like structures from mouse extended pluripotent stem cells
por: Li, Ronghui, et al.
Publicado: (2021)

Author Correction: Disrupted Ca(2+) homeostasis and immunodeficiency in patients with functional IP(3) receptor subtype 3 defects
por: Neumann, Julika, et al.
Publicado: (2022)

Correction to: Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma
por: Kremer, Veronika, et al.
Publicado: (2017)

Correction: Harnessing Soluble NK Cell Killer Receptors for the Generation of Novel Cancer Immune Therapy
por: Arnon, Tal I., et al.
Publicado: (2008)

Correction: Uterine NK Cells Are Critical in Shaping DC Immunogenic Functions Compatible with Pregnancy Progression
por: Tirado-González, Irene, et al.
Publicado: (2012)

Correction: Harnessing Soluble NK Cell Killer Receptors for the Generation of Novel Cancer Immune Therapy
por: Arnon, Tal I., et al.
Publicado: (2015)

Correction: NK cell–derived GM-CSF potentiates inflammatory arthritis and is negatively regulated by CIS
por: Louis, Cynthia, et al.
Publicado: (2020)

Correction: TGFβ drives NK cell metabolic dysfunction in human metastatic breast cancer
Publicado: (2021)

Use of Customizable Nucleases for Gene Editing and Other Novel Applications
por: Reddy, Pradeep, et al.
Publicado: (2020)

The Race of CAR Therapies: CAR-NK Cells for Fighting B-Cell Hematological Cancers
por: Herrera, Lara, et al.
Publicado: (2021)

Correction: Defective chromatin architectures in embryonic stem cells derived from somatic cell nuclear transfer impair their differentiation potentials
por: Wu, Dan-Ya, et al.
Publicado: (2021)

Author Correction: Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins
por: Pavani, Giulia, et al.
Publicado: (2020)

Novel Genome-Editing Tools to Model and Correct Primary Immunodeficiencies
por: Ott de Bruin, Lisa M., et al.
Publicado: (2015)

Correction: A novel human IL2RB mutation results in T and NK cell–driven immune dysregulation
por: Fernandez, Isabel Z., et al.
Publicado: (2019)

Albumin-Associated Lipids Regulate Human Embryonic Stem Cell Self-Renewal
por: Garcia-Gonzalo, Francesc R., et al.
Publicado: (2008)

Gene Editing Correction of a Urea Cycle Defect in Organoid Stem Cell Derived Hepatocyte-like Cells
por: Zabulica, Mihaela, et al.
Publicado: (2021)

Gene-edited and CAR-NK cells: Opportunities and challenges with engineering of NK cells for immunotherapy
por: Wu, Xinyu, et al.
Publicado: (2022)

Correction: iRGD-modified memory-like NK cells exhibit potent responses to hepatocellular carcinoma
por: Dong, Yanbing, et al.
Publicado: (2023)

Natural Killer Cells for Cancer Immunotherapy: Pluripotent Stem Cells-Derived NK Cells as an Immunotherapeutic Perspective
por: Eguizabal, Cristina, et al.
Publicado: (2014)

Autophagic control of cell ‘stemness’
por: Pan, Huize, et al.
Publicado: (2013)

Adult peripheral blood and umbilical cord blood NK cells are good sources for effective CAR therapy against CD19 positive leukemic cells
por: Herrera, L., et al.
Publicado: (2019)

Correction to: Treatment of periodontal intrabony defects using autologous periodontal ligament stem cells: a randomized clinical trial
por: Chen, Fa-Ming, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_emdj3ll95ku6l571k822en65qf